Clinical Trial Update: Influence of Exceptional Patient Characteristics on Everolimus Exposure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating how exceptional patient characteristics influence everolimus exposure in breast neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Neoplasms

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Breast Neoplasms | Phase 4 | Status: COMPLETED